Download PDF
Synlett 2010(4): 563-566  
DOI: 10.1055/s-0029-1219208
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Progress towards the Total Synthesis of Scytonemin A: Asymmetric Synthesis of (2S,3R,4R)-4-hydroxy-3-methylproline

Lei Wanga, Junyang Liua, Hui Zhanga, Zhengshuang Xu*a,b, Tao Ye*a,b
a Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, University Town of Shenzhen, Xili, Nanshan District, Shenzhen 518055, P. R. of China
e-Mail: xuzs@szpku.edu.cn;
b Department of Applied Biology & Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong
Fax: +852(2)2641912; e-Mail: bctaoye@inet.polyu.edu.hk;
Further Information

Publication History

Received 19 November 2009
Publication Date:
19 January 2010 (online)

    Permissions and Reprints All articles of this category

Abstract

During the total synthesis of the novel cyclopeptide scytonemin A, the fragment containing two (2S,3R,4R)-4-hydroxy-3-methylproline units was successfully prepared. Two approaches leading to (2S,3R,4R)-4-hydroxy-3-methylproline have been explored. They involve the following key transformations: asymmetric crotylation, Sharpless epoxidation-subsequent epoxide opening, intramolecular amidomercuration-oxidation.

Key words

scytonemin A - cyclopeptide - substituted proline - amino acids - asymmetric synthesis

    References and Notes

  • 1a Ebel R. In Frontiers in Marine Biotechnology   Proksch P. Muller WEG. Horizon Bioscience; England: 2006.  p.73-144  
    Google Scholar
  • 1b Ramaswamy AV. Flatt PM. Edwards DJ. Simmons TL. Han B. Gerwick WH. In Frontiers in Marine Biotechnology   Proksch P. Muller WEG. Horizon Bioscience; England: 2006.  p.175-224  
    Google Scholar
  • 1c Drugs from the Sea   Fusetani N. S. Karger AG; Basel: 2000. 
    Google Scholar
  • 1d Fusetani N. Matsunaga S. Chem. Rev.  1993,  93:  1793 
    Google Scholar
  • 1e Davidson BS. Chem. Rev.  1993,  93:  1771 
    Google Scholar
  • 2a Proksch P. Edrada R. Lin WH. In Frontiers in Marine Biotechnology   Proksch P. Muller WEG. Horizon Bioscience; England: 2006.  p.1-20  
    Google Scholar
  • 2b Newman DJ. Gragg GM. J. Nat. Prod.  2004,  67:  1216 
    Google Scholar
  • 2c Proksch P. Edrada RA. Ebel R. Appl. Microbiol. Biotechnol.  2002,  59:  125 
    Google Scholar
  • 2d Frenz JL. Kohl AC. Kerr RG. Expert Opin. Ther. Pat.  2004,  14:  17 
    Google Scholar
  • 2e Wipf P. Chem. Rev.  1995,  95:  2115 
    Google Scholar
  • 3 Helms GL. Moore RE. Niemczura WP. Patterson GML. J. Org. Chem.  1988,  53:  1298 
    CrossrefGoogle Scholar
  • 4a Liang S. Xu Z. Ye T. Chem. Commun.  2010,  46: in press; DOI: 10.1039/b921000h
    Google Scholar
  • 4b Li S. Liang S. Tan WF. Xu ZS. Ye T. Tetrahedron  2009,  65:  2695 
    Google Scholar
  • 4c Ren Q. Dai L. Zhang H. Tan WF. Xu ZS. Ye T. Synlett  2008,  2379 
    Google Scholar
  • 4d Li S. Liang S. Xu ZS. Ye T. Synlett  2008,  569 
    Google Scholar
  • 4e Chen Z. Ye T. New J. Chem.  2006,  30:  518 
    Google Scholar
  • 4f Pang HW. Xu ZS. Chen ZY. Ye T. Lett. Org. Chem.  2005,  2:  699 
    Google Scholar
  • 4g Peng YG. Pang HW. Xu ZS. Ye T. Lett. Org. Chem.  2005,  2:  703 
    Google Scholar
  • 4h Xu ZS. Ye T. Tetrahedron: Asymmetry  2005,  16:  1905 
    Google Scholar
  • 4i Chen HL. Xu ZS. Ye T. Tetrahedron  2005,  61:  11132 
    Google Scholar
  • 4j Chen ZY. Ye T. Synlett  2005,  2781 
    Google Scholar
  • 4k Xu ZS. Chen Z. Ye T. Tetrahedron: Asymmetry  2004,  15:  355 
    Google Scholar
  • 4l Peng YG. Pang HW. Ye T. Org. Lett.  2004,  6:  3781 
    Google Scholar
  • 4m Chen ZY. Deng JGYeT. ARKIVOC  2003,  (vii):  268 
    Google Scholar
  • 4n Xu ZS. Peng YG. Ye T. Org. Lett.  2003,  5:  2821 
    Google Scholar
  • For the synthesis of racemic and enantiomerically enriched 4-hydroxy-3-methylproline, please see:
  • 5a Anderson JC. Flaherty A. J. Chem. Soc., Perkin Trans. 1  2001,  267 
    Google Scholar
  • 5b Anderson JC. O’Loughlina JMA. Tornos JA. Org. Biomol. Chem.  2005,  3:  2741 
    Google Scholar
  • 6a Brown HC. Bhat KS. J. Am. Chem. Soc.  1986,  108:  293 
    Google Scholar
  • 6b Brown HC. Bhat KS. Randad RS. J. Org. Chem.  1989,  54:  1570 
    Google Scholar
  • 7a Harding KE. Burks SR. J. Org. Chem.  1981,  46:  3920 
    Google Scholar
  • 7b Harding KE. Burks SR. J. Org. Chem.  1984,  49:  40 
    Google Scholar
  • 7c Harding KE. Marman TH. J. Org. Chem.  1984,  49:  2838 
    Google Scholar
  • 7d Kinsman R. Lathbury D. Vernon P. Gallagher T. J. Chem. Soc., Chem. Commun.  1987,  243 
    Google Scholar
  • 7e Tokuda M. Yamada Y. Suginome H. Chem. Lett.  1988,  17:  1289 
    Google Scholar
  • 7f Takahata H. Takehara H. Ohkubo N. Momose T. Tetrahedron: Asymmetry  1990,  1:  561 
    Google Scholar
  • 7g Takahata H. Bandoh H. Momose T. Tetrahedron: Asymmetry  1991,  2:  351 
    Google Scholar
  • 7h Singh S. Chikkanna D. Singh OV. Han H. Synlett  2003,  1279 
    Google Scholar
  • 7i Khalaf JK. Datta A. J. Org. Chem.  2004,  69:  387 
    Google Scholar
  • 7j Chikkanna D. Han H. Synlett  2004,  2311 
    Google Scholar
  • 8a Katsuki T. Sharpless KB. J. Am. Chem. Soc.  1980,  102:  5974 
    Google Scholar
  • 8b Gao Y. Hanson RM. Klunder JM. Ko SY. Masamune H. Sharpless KB. J. Am. Chem. Soc.  1987,  109:  5765 
    Google Scholar
  • 9a Markad SD. Karanjule NS. Sharma T. Sabharwal SG. Puranik VG. Dhavale DD. Org. Biomol. Chem.  2006,  4:  2549 
    Google Scholar
  • 9b Benedetti F. Berti F. Dinon F. Nardin G. Norbedo S. Org. Lett.  2004,  6:  1017 
    Google Scholar
  • 9c Saotome C. Kanie Y. Kanie O. Wong C.-H. Bioorg. Med. Chem.  2000,  8:  2249 
    Google Scholar
  • 9d Beier C. Schaumann E. Synthesis  1997,  1296 
    Google Scholar
  • 9e Gleave DM. Brickner SJ. J. Org. Chem.  1996,  61:  6470 
    Google Scholar
  • 9f Kim NS. Choi JR. Cha JK. J. Org. Chem.  1993,  58:  7096 
    Google Scholar
  • 9g Carpenter NM. Fleet GWJ. Di Bello IC. Winchester B. Fellows LE. Nash RJ. Tetrahedron Lett.  1989,  30:  7261 
    Google Scholar
  • 10 De Luca L. Giacomelli G. Porcheddu A. Org. Lett.  2001,  3:  3041 
    CrossrefPubMedGoogle Scholar
  • 11 Yu W. Mei Y. Kang Y. Hua Z. Jin Z. Org. Lett.  2004,  6:  3217 
    CrossrefPubMedGoogle Scholar
  • 13 Bal BS. Childers WE. Pinnick HW. Tetrahedron  1981,  37:  2091 
    CrossrefGoogle Scholar
  • 14 Sarraf ST. Leighton JL. Org. Lett.  2000,  2:  403 
    CrossrefPubMedGoogle Scholar
12

Procedure for the Synthesis of 4 via Epoxide Opening
Epoxide 5 (0.65 g, 1.6 mmol) was dissolved in MeOH (10 mL). After a catalytic amount of Pd/C (10%) was added, the reaction was exposed to an atmosphere of H2 at ambient temperature. The reaction was monitored by TLC. After all starting material was consumed (ca. 2 h), the reaction mixture was stirred for an additional 1 h and then filtered through a pad of Celite. The filter cake was washed with MeOH (10 mL). The combined filtrate and washings were concentrated in vacuo to leave the corresponding amine as an oil, which was dissolved in THF-H2O (20 mL, 1:1) at 0 ˚C and treated with NaHCO3 (0.25 g, 3.0 mmol) and CbzCl (0.29 mL, 2.0 mmol). The reaction mixture was stirred at r.t. for 3 h and then concentrated in vacuo. The residue was extracted with EtOAc (3 × 20 mL). The combined organic phases were washed with brine (30 mL), dried over anhydrous Na2SO4, and concentrated in vacuo. The residue was purified by flash chromatography on silica gel, eluting with EtOAc-hexane (2:3) to give desired product 4 (0.49 g, 75%); [a]D ²5 -6.6 (c 0.70, CHCl3). ¹H NMR (500 MHz, CDCl3): δ = 7.40-7.29 (m, 5 H), 5.17 (s, 2 H), 4.17 (d, J = 3.3 Hz, 1 H), 4.11 (d, J = 9.0 Hz, 1 H), 3.73 (dd, J = 4.2, 7.1 Hz, 1 H), 3.61-3.58 (m, 4 H), 3.34 (dd, J = 4.1, 11.6 Hz, 1 H), 3.09-3.07 (m, 1 H), 2.18 (dd, J = 6.9, 11.5 Hz, 1 H), 1.12 (d, J = 6.9 Hz, 3 H), 0.88 (s, 9 H), 0.07 (s, 3 H), 0.04 (s, 3 H). ¹³C NMR (125 MHz, CDCl3): δ = 157.7, 136.3, 128.5 (128.5), 128.2, 128.0 (127.9), 73.4, 72.2, 67.6, 65.7, 62.9, 54.5, 41.4, 25.8 (25.7), 18.0, 13.0, -4.9, -5.0 ppm. ESI-HRMS: m/z calcd for C21H36NO5Si+ [M + H]+: 410.2351; found: 410.2375.

15

Procedure for the Synthesis of 11 via Amidomercuration-Oxidation
To a stirred solution of compound 8 (0.88 g, 2.40 mmol) in MeCN (20 mL), Hg(OAc)2 (2.26 g, 7.20 mmol) was added. The reaction mixture was refluxed for 2 h and then cooled to r.t. EtOAc (10 mL) and brine (10 mL) were added, and the mixture was stirred at r.t. for a further 1.5 h and filtered to remove the precipitated inorganic byproduct. The filtrate was separated and the aqueous layer was extracted with EtOAc (3 × 50 mL). The combined organic phases were dried over anhydrous Na2SO4 and concentrated in vacuo to give 7 as a colorless foam. In a second reaction vessel, oxygen (O2) was bubbled into a well-stirred solution of NaBH4 (0.09 g, 2.4 mmol) in DMF (25 mL) at r.t. One hour later, the above intermediate in DMF (25 mL) was slowly added over 2 h, while maintaining the flow of oxygen. Upon completion of addition, the reaction mixture was stirred for additional 2 h and then filtered through a pad of Celite, eluting thoroughly with EtOAc (200 mL). The filtrate was concentrated in vacuo, and the residue was purified by flash chromatography (EtOAc-hexane, 3:1) to afford the diastereoisomers 11α (0.23 g, 26%) and 11β (0.22 g, 24%).
Analytical Data for 11α
[α]D ²5 +28.6 (c 0.54, CHCl3). ¹H NMR (500 MHz, CDCl3); δ = 7.37-7.27 (m, 5 H), 5.22-5.09 (m, 2 H), 4.24-4.02 (m, 2 H), 3.94-3.79 (m, 2 H), 3.72-3.66 (m, 1 H), 3.60-3.55 (m, 1 H), 3.52-3.42 (m, 1 H), 2.46-2.33 (m, 1 H), 1.07 (1.05) (d, J = 7.4 Hz, 3 H), 0.92 (0.91) (s, 9 H), 0.14 (0.09) (s, 6 H) ppm. ¹³C NMR (125 MHz, CDCl3): δ = 156.1 (154.9), 136.7, 128.5, 128.0, 127.9, 73.4 (72.8), 67.1, 62.8 (61.9), 61.5 (59.8), 56.1 (55.4), 41.4 (40.7), 25.7, 18.0, 9.9 (9.7), -4.8,
-5.1 ppm. ESI-HRMS: m/z calcd for C20H34NO4Si+ [M + H]+: 380.2252; found: 380.2268.
Analytical Data for 11β [α]D ²5 -2.0 (c 0.16, CHCl3). ¹H NMR (500 MHz, CDCl3):
δ = 7.38-7.33 (m, 5 H), 5.35-5.10 (m, 2 H), 4.85 (br, 1 H) 4.05 (br, 1 H), 3.82-3.80 (m, 1 H), 3.70-3.66 (m, 1 H), 3.62-3.58 (m, 2 H), 3.38 (dd, J = 3.0, 13.4 Hz, 1 H), 1.84-1.77 (m, 1 H), 1.06 (d, J = 6.7 Hz, 3 H), 0.87 (s, 9 H), 0.06 (s, 3 H), 0.04 (s, 3 H) ppm. ¹³C NMR (125 MHz, CDCl3): δ = 157.4, 136.4, 128.5, 128.0, 127.8, 72.3, 67.3, 65.9, 65.6, 55.6, 41.4, 25.7, 18.0, 11.9, -4.8, -5.0 ppm. ESI-HRMS: m/z calcd for C20H34NO4Si+ [M + H]+: 380.2252; found: 380.2264.

16

See Supporting Information.